HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial.

AbstractAIM:
We aimed to compare the relative efficacy of tropisetron and metoclopramide in treating nausea/vomiting in undifferentiated ED patients.
METHODS:
We undertook a randomized, double-blinded, clinical trial. Adult patients requiring treatment for nausea/vomiting were randomly assigned to either tropisetron (5 mg) or metoclopramide (10 mg), by i.v. bolus. The primary end-point was incidence of vomiting. Secondary end-points were decrease in nausea score from baseline (0-100 VAS), the requirement of 'rescue' anti-emetics, ongoing nausea over 48 h and side-effects.
RESULTS:
Fifty patients were enrolled in each group. The demographic variables, presenting complaints and nausea scores at baseline did not differ (P > 0.05). By 180 min, two (4.0%) and nine (18.0%) patients had vomited in the tropisetron and metoclopramide groups respectively (difference 14.0%, 95% CI 0.1-28.0, P= 0.05). Also, there were two and 20 episodes of vomiting respectively. Vomiting rates were 0.02 and 0.16 episodes/person-hour (difference 0.14 episodes/person-hour, 95% CI 0.07-0.21, P < 0.001) respectively. By 60 min and thereafter, the decrease in nausea score from baseline was greater (although not significantly so) in the tropisetron group. At 180 min, the decreases were 47.9 mm and 37.0 mm respectively (difference 10.9 mm, 95% CI -0.7-22.6). Five (10.0%) and 13 (26.0%) patients required a rescue anti-emetic respectively (difference 16.0%, 95% CI -0.7-32.7, P= 0.07). Of patients followed up, 13/47 (27.7%) and 20/49 (40.8%) had ongoing nausea respectively (difference 13.2%, 95% CI -7.7-34.0, P= 0.25). The tropisetron group had less akathisia.
CONCLUSIONS:
Tropisetron was associated with a significantly lower vomiting rate and shows promise as an alternative anti-emetic in the ED.
AuthorsJohn Chae, David McD Taylor, Albert G Frauman
JournalEmergency medicine Australasia : EMA (Emerg Med Australas) Vol. 23 Issue 5 Pg. 554-61 (Oct 2011) ISSN: 1742-6723 [Electronic] Australia
PMID21995469 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2011 The Authors. EMA © 2011 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine.
Chemical References
  • Antiemetics
  • Indoles
  • Tropisetron
  • Metoclopramide
Topics
  • Adult
  • Aged
  • Antiemetics (therapeutic use)
  • Double-Blind Method
  • Emergency Medical Services (methods)
  • Emergency Service, Hospital
  • Female
  • Humans
  • Incidence
  • Indoles (therapeutic use)
  • Male
  • Metoclopramide (therapeutic use)
  • Middle Aged
  • Nausea (drug therapy)
  • Tropisetron
  • Vomiting (drug therapy, epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: